Nesw Fewer Acquisitions And Alliances In 2023, But Valuations Increased

INFOGRAPHIC: Deal volume for both M&A and alliances fell in 2023, but average valuations rose appreciably. Antibody-drug conjugates for cancer drove high-value acquisitions and partnerships.

 
• By Joseph Haas
Puzzle
In both M&A and alliances, 2023 saw lower deal volume but higher deal valuations • Source: Shutterstock

More from In Vivo Archive

More from In Vivo